Skip to main content

Leheny A. Rachel's Form 4/A amendment

Amended

CalciMedica, Inc. (CALC) · filed Jun 15, 2023

Accession no.
0001209191-23-037586
Filed
Jun 15, 2023
Trade date
Jun 8, 2023
Filing delay
7 days
Rule 10b5-1 plan
Not checked
Original filed
Jun 9, 2023

This filing lists 1 non-derivative transaction. It carries over 1 transaction from the original filing that it did not restate. Open-market purchases total $7.33K. It was filed 7 days after the trade.

This amendment restates part of 0001209191-23-036127 (filed Jun 9, 2023). The transactions it did not restate still count and are listed below.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Leheny A. RachelCIK 0001484729Director, Officer (Chief Executive Officer), 10% Owner

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Jun 8, 2023Common StockPPurchaseAcquired+1,000$5.23F1+$5,2309,000Direct

Carried over from the original filing

This amendment restates only part of the original filing. The original's other transactions still stand, and the trade tables on Livermore count them under this amendment.

From 0001209191-23-036127 (filed Jun 9, 2023).

Non-derivative securities (Table I)

Non-derivative transactions carried over from 0001209191-23-036127
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Jun 9, 2023Common StockPPurchaseAcquired+400$5.25+$2,1009,328Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F1

The weighted average purchase price for the transaction reported was $5.225, and the range of prices were between $5.20 and $5.25. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares purchased at each separate price will be provided.

Referenced by the price of 1 transaction in Table I.

Remarks

On June 9, 2023, the reporting person filed a Form 4 which incorrectly stated a total of 928 shares were purchased on June 8, 2023. A total of 1,000 shares were purchased by the reporting person on June 8, 2023 as stated in this amendment.

Read the full filing on SEC EDGAR (opens in a new tab)